Astera Labs ALAB · NASDAQ
$285.82 -5.35% (-$16.16)
Summary
66 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 31 USD is left as net profit.
- Revenue grew by 120% a year over the last 3 years.
- It has no debt and holds $111.5M in cash.
- Analysts expect revenue to grow by 124% this fiscal year.
What to watch
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveToday you pay 134.2 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 120% a year over the last 3 years. For the next fiscal year analysts expect revenue to grow by 124%.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 25 USD
- Research and development 36 USD
- Sales and administration 16 USD
- Taxes and other -8.0 USD
- Net profit 31 USD
Net profit, industry median (Semiconductors) 11 USD
Out of every 100 USD of revenue, 31 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 13
- Hold 5
- Sell 0
Today's price within the analysts' price targets
The average target of $370.42 is 30% above today's price. 72% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reportable Segment 100%
By region
- SINGAPORE 32%
- CHINA 30%
- TAIWAN 29%
- Non-US 5.2%
- UNITED STATES 3.2%
Reportable Segment brings in 100% of revenue.
Segments in detail